Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

  • Price (USD)30.22
  • Today's Change-0.165 / -0.54%
  • Shares traded155.93k
  • 1 Year change-21.66%
  • Beta0.6641
Data delayed at least 15 minutes, as of Oct 18 2019 17:39 BST.
More ▼

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.

  • Revenue in USD (TTM)3.05bn
  • Net income in USD-197.69m
  • Incorporated2005
  • Employees28.60k
  • Location
    Acadia Healthcare Company Inc6100 Tower Cir Ste 1000FRANKLIN 37067-1509United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttp://www.acadiahealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Irhythm Technologies Inc181.80m-44.44m1.91bn748.00--36.90--10.49-1.82-1.827.461.961.1118.227.54243,053.50-27.08-34.82-32.57-41.7075.2369.42-24.45-37.322.59-18.080.4181--49.5257.15-64.11--62.87--
MEDNAX Inc3.55bn202.96m2.00bn7.63k10.260.7326.630.56292.31-1.5240.7032.400.6173--6.88465,421.603.536.283.816.93----5.729.65--4.170.4329--5.4611.117.29-0.862325.57--
Livongo Health Inc112.94m-52.39m2.00bn538.00------17.75-0.5762-0.57621.241.35------293,337.70--------68.58---46.20--2.36--0.00--121.82---97.31------
NeoGenomics, Inc.342.86m1.94m2.12bn1.50k1,032.344.33102.986.190.01980.01983.574.720.657822.694.55228,574.000.3728-0.59870.4155-0.680748.2744.010.5667-0.88724.523.200.1832--15.1933.01143.6624.5348.06--
The Ensign Group, Inc.2.18bn103.20m2.18bn23.46k21.953.3314.231.001.861.8639.3212.291.26--7.9592,784.556.006.487.228.3217.3912.914.753.54--11.050.291314.7610.3517.67108.0729.0136.356.72
Senior Housing Properties Trust1.09bn-79.89m2.23bn600.00--0.772910.412.04-0.3363-0.33634.6012.150.1503----1,820,800.00-1.042.59-1.062.6356.9061.38-6.8917.09--0.96620.553205.723.957.9794.349.32-1.020.00
Select Medical Holdings Corporation5.22bn138.50m2.28bn33.70k15.892.695.770.43771.061.0639.936.250.7984--6.66154,839.102.843.293.774.2514.4814.343.563.50--2.370.647911.2816.4011.3033.393.5517.83--
Tenet Healthcare Corp18.21bn-26.00m2.43bn90.09k----2.100.1335-0.256-0.159176.69-1.050.79979.816.61202,164.501.470.68162.050.93783.6683.971.830.80561.061.870.873---4.5210.53123.58---2.24--
Agape ATP Corp1.55m-519.64k2.45bn----533.97--1,581.95-0.0014-0.00140.00410.01220.3137-------10.54---10.74--7.07---33.61-----1.800.00--217.46---298.89------
Option Care Health Inc735.00m-59.76m2.50bn1.66k------3.41-0.4662-0.47825.74-0.58321.2618.266.84443,574.50-8.22-20.26-9.90-25.6034.0629.43-6.52-15.421.290.41271.17---13.250.354455.49---11.53--
Myokardia Inc21.59m-107.11m2.62bn210.00--4.49--121.58-2.54-2.540.517312.670.0411----130,836.40-20.40-20.49-22.05-24.65-----496.15-163.29----0.00--193.29---18.75--23.61--
Genomic Health, Inc.428.78m50.72m2.65bn829.0053.678.2941.626.181.321.3011.118.511.23--8.30517,220.8014.59-4.6616.88-5.7984.6582.8511.83-3.04----0.0011--15.668.54781.28---1.75--
Acadia Healthcare Company Inc3.05bn-197.69m2.69bn28.60k--1.10--0.8805-2.26-2.3834.8627.640.4595--9.04106,798.70-2.970.893-3.180.9566-----6.461.771.082.090.57320.006.2133.39-198.06--36.11--
HMS Holdings Corp626.21m100.71m3.00bn2.50k29.913.7519.124.781.,483.609.463.4210.193.7935.8529.4316.086.18--13.260.23160.0014.794.00120.636.573.36--
Data as of Oct 18 2019. Currency figures normalised to Acadia Healthcare Company Inc's reporting currency: US Dollar USD

Institutional shareholders

78.57%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 201912.95m14.63%
Wellington Management Co. LLPas of 30 Jun 201910.57m11.94%
The Vanguard Group, Inc.as of 30 Jun 20197.95m8.98%
Aristotle Capital Management LLCas of 30 Jun 20197.41m8.37%
BlackRock Fund Advisorsas of 30 Jun 20197.41m8.37%
P2 Capital Partners LLCas of 19 Sep 20196.43m7.26%
Dimensional Fund Advisors LPas of 30 Jun 20196.28m7.10%
Elliott Management Corp.as of 30 Jun 20194.35m4.91%
JPMorgan Investment Management, Inc.as of 30 Jun 20193.61m4.08%
Ares Management LLCas of 30 Jun 20192.60m2.94%
More ▼
Data from 30 Jun 2019 - 30 Jun 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.